Yi Luo

2.6k total citations · 1 hit paper
72 papers, 1.5k citations indexed

About

Yi Luo is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Yi Luo has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 22 papers in Infectious Diseases and 13 papers in Health. Recurrent topics in Yi Luo's work include Herpesvirus Infections and Treatments (25 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and Vaccine Coverage and Hesitancy (13 papers). Yi Luo is often cited by papers focused on Herpesvirus Infections and Treatments (25 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and Vaccine Coverage and Hesitancy (13 papers). Yi Luo collaborates with scholars based in United States, China and Netherlands. Yi Luo's co-authors include Hung Fu Tseng, Lina S. Sy, Bradley K. Ackerson, Katia Bruxvoort, Lei Qian, Zendi Solano, Yun Tian, Christine A. Fischetti, Carla Talarico and Ana Florea and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yi Luo

64 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

2022 315 citations Hung Fu Tseng, Bradley K. Ackerson et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Luo United States	18	770	686	286	134	130	72	1.5k
Joan Puig‐Barberà Spain	26	2.2k 2.9×	550 0.8×	382 1.3×	124 0.9×	262 2.0×	100	2.7k
Manisha Patel United States	22	1.6k 2.1×	514 0.7×	743 2.6×	49 0.4×	128 1.0×	67	2.2k
Ned Lewis United States	23	1.0k 1.3×	780 1.1×	464 1.6×	61 0.5×	30 0.2×	55	2.0k
Marco Goeijenbier Netherlands	22	412 0.5×	742 1.1×	92 0.3×	118 0.9×	88 0.7×	59	1.4k
Karlis Pauksens Sweden	23	964 1.3×	385 0.6×	50 0.2×	77 0.6×	133 1.0×	47	1.6k
Maria Cano United States	22	1.1k 1.4×	482 0.7×	473 1.7×	30 0.2×	34 0.3×	54	1.7k
Bruno Lewin United States	16	244 0.3×	672 1.0×	233 0.8×	22 0.2×	42 0.3×	67	1.2k
Sarah Reagan-Steiner United States	11	1.0k 1.3×	477 0.7×	514 1.8×	55 0.4×	35 0.3×	23	1.6k
Eithne MacMahon United Kingdom	19	606 0.8×	339 0.5×	104 0.4×	34 0.3×	38 0.3×	42	1.1k
Su Eun Park South Korea	15	386 0.5×	385 0.6×	99 0.3×	101 0.8×	20 0.2×	96	1.2k

Countries citing papers authored by Yi Luo

Since Specialization

Citations

This map shows the geographic impact of Yi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Luo more than expected).

Fields of papers citing papers by Yi Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Luo. The network helps show where Yi Luo may publish in the future.

Co-authorship network of co-authors of Yi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Luo. A scholar is included among the top collaborators of Yi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Luo. Yi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Haens, Geert, Silvio Danese, Remo Panaccione, et al.. (2025). Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn’s disease and ulcerative colitis. Journal of Crohn s and Colitis. 19(6).

Rayens, Emily, Lina S. Sy, Lei Qian, et al.. (2025). Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study. Annals of the Rheumatic Diseases. 84(6). 960–969. 1 indexed citations

Rayens, Emily, Lina S. Sy, Lei Qian, et al.. (2025). Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. Clinical Infectious Diseases. 81(5). e441–e445.

Ku, Jennifer H, Afshan Nanji, Julia E. Tubert, et al.. (2024). Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System. American Journal of Ophthalmology. 263. 133–140.

Rayens, Emily, Jennifer H Ku, Lina S. Sy, et al.. (2024). Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years. Influenza and Other Respiratory Viruses. 18(12). e70025–e70025. 2 indexed citations

Luo, Yi, et al.. (2024). Global Infectious Diseases from April-June 2024: Periodic Analysis. SHILAP Revista de lepidopterología. 4(1).

Tseng, Hung Fu, Bradley K. Ackerson, Katia Bruxvoort, et al.. (2023). Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nature Communications. 14(1). 189–189. 47 indexed citations

Luo, Yi, et al.. (2023). Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis. Journal of Orthopaedic Surgery and Research. 18(1). 867–867. 1 indexed citations

Liu, Wei, Jia Huang, Yi Luo, et al.. (2023). Correlating metal exposures and dietary habits with hyperuricemia in a large urban elderly cohort by artificial intelligence. Environmental Science and Pollution Research. 30(14). 41570–41580. 2 indexed citations

10.

Zhang, Shuqiong, et al.. (2023). Global Infectious Diseases in April 2023: Monthly Analysis. SHILAP Revista de lepidopterología. 3(1). 1 indexed citations

11.

Ku, Jennifer H, Lina S. Sy, Lei Qian, et al.. (2023). Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study. Vaccine. 41(29). 4212–4219. 4 indexed citations

12.

Huang, Chao, Wei Liu, Yi Luo, et al.. (2023). The relative and interactive effects of urinary multiple metals exposure on hyperuricemia among urban elderly in China. Frontiers in Public Health. 11. 1015202–1015202. 7 indexed citations

13.

Luo, Yi, et al.. (2022). Global Infectious Diseases in August of 2022: Monthly Analysis. SHILAP Revista de lepidopterología. 2(1). 1 indexed citations

14.

Liu, Dongliang, et al.. (2022). Global Infectious Diseases in September 2022: Monthly Analysis. SHILAP Revista de lepidopterología. 2(1).

15.

Tseng, Hung Fu, Bradley K. Ackerson, Yi Luo, et al.. (2022). Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nature Medicine. 28(5). 1063–1071. 315 indexed citations breakdown →

16.

Bruxvoort, Katia, Bradley K. Ackerson, Lina S. Sy, et al.. (2021). Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults. The Journal of Infectious Diseases. 225(11). 1915–1922. 30 indexed citations

17.

Becerra-Culqui, Tracy A., Lina S. Sy, Bradley K. Ackerson, et al.. (2019). Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine. 38(2). 228–234. 4 indexed citations

18.

Hechter, Rulin C., Lei Qian, Songkai Yan, et al.. (2017). Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization. BMC Health Services Research. 17(1). 503–503. 6 indexed citations

19.

Zhu, Yingying, Ying Wan, Yi Luo, et al.. (2015). Potential influencing factors of time from onset to clinical diagnosis and misdiagnosis rate of Parkinson's patients in Shanghai. Chin J Neurol. 48(11). 995–999. 1 indexed citations

20.

Tseng, Hung Fu, Sara Y. Tartof, Rafael Harpaz, et al.. (2014). Vaccination Against Zoster Remains Effective in Older Adults Who Later Undergo Chemotherapy. Clinical Infectious Diseases. 59(7). 913–919. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact